Moelis (MC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

TG Therapeutics (TGTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Investment analysts at Zacks Research decreased their FY2024 earnings per share (EPS) estimates for Intercontinental Exchange in a report issued on Tuesday, January 28th. Zacks Research analyst T. De ...

Whether you're a growth, value, income, or momentum-focused investor, building a successful investment portfolio takes skill, research, and a little bit of luck. But what's the best way to find the ...

Building a successful investment portfolio takes skill and hard work, no matter if you're a growth, value, income, or momentum-focused investor. How do you find the right combination of stocks that ...

Research analysts at Zacks Research cut their Q3 2027 EPS estimates for Haemonetics in a note issued to investors on Wednesday, January 29th. Zacks Research analyst R. Department now forecasts that ...

VALE (VALE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Imperial Oil (IMO) delivered earnings and revenue surprises of 19.01% and 19.54%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?